The global Neuroendocrine Tumour Treatment market size is projected to reach USD 2,302.3 million by 2027, from USD 1,498.4 million in 2020, at a CAGR of 5.9% during 2021-2028.
Increasing cases of neuroendocrine tumours (NETs) are some of the factors that have supported long-term expansion for the Neuroendocrine Tumour Treatment Market.
Neuroendocrine Tumour Treatment Market is segmented into product, site, end-use and geography.
The product segment is segmented into somatostatin analogues (SSAs), targeted therapy and others.
Site segment is segmented into lungs, pancreas, colon, and small intestine.
The end-user segment is segmented into hospitals and clinics.
Geographically, Neuroendocrine Tumour Treatment Market is sub-segmented into North America, Europe, Asia-Pacific, Middle East and Africa and South America and insights are provided for each region and major countries within the regions
Key players in Neuroendocrine Tumour Treatment Market are Novartis AG; Boehringer Ingelheim International GmbH; Pfizer, Inc.; and Ipsen Pharma. Several other companies in the market include AVEO Oncology, Hutchison MediPharma Limited, and Progenics Pharmaceuticals.
|
Report Feature |
Descriptions |
|---|---|
|
Market Revenue In 2021 |
USD 1,498.4 million |
|
Growth Rate |
CAGR of 5.9% during the forecasting period, 2021-2028 |
|
Historical Data |
2018-2019 |
|
Forecast Years |
2021-2028 |
|
Base Year |
2020 |
|
Units Considered |
Revenue in USD million and CAGR from 2021 to 2028 |
|
Report Segmentation |
product, site, end-use and geography |
|
Report Attribute |
Market Revenue Sizing (Global, Regional and Country Level) Company Share Analysis, Market Dynamics, Company Profiling |
|
Regional Level Scope |
North America, Europe, Asia-Pacific, South America, and the Middle East and Africa |
|
Country Level Scope |
U.S., Japan, Germany, U.K., China, India, Brazil, UAE, South Africa (50+ Countries Across the Globe) |
|
Companies Profiled |
Novartis AG; Boehringer Ingelheim International GmbH; Pfizer, Inc.; and Ipsen Pharma. Several other companies in the market include AVEO Oncology, Hutchison MediPharma Limited, and Progenics Pharmaceuticals |
|
Available Customization |
In addition to the market data for Neuroendocrine Tumour Treatment Market, Delvens offers client-centric reports and customized according to the company’s specific demand and requirement. |
.png)
.png)
.png)
.png)
.png)
.png)